Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023).

Article  PubMed  Google Scholar 

Bladé, J. et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 12, 45 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Kyle, R. A. et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 78, 21–33 (2003).

Article  PubMed  Google Scholar 

Alaggio, R. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36, 1720–1748 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Wadhera, R. K. & Rajkumar, S. V. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin. Proc. 85, 933–942 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Han, J.-h et al. Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China. Blood Cancer J. 10, 34 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Hungria, V. T. et al. Observational study of multiple myeloma in Latin America. Ann. Hematol. 96, 65–72 (2017).

Article  CAS  PubMed  Google Scholar 

Colunga-Pedraza, P. R., Gomez-Cruz, G. B., Colunga-Pedraza, J. E. & Ruiz-Argüelles, G. J. Geographic hematology: some observations in Mexico. Acta Haematol. 140, 114–120 (2018).

Article  PubMed  Google Scholar 

Turesson, I. et al. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur. J. Haematol. https://doi.org/10.1111/ejh.13083 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Cowan, A. J. et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 4, 1221–1227 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Padala, S. A. et al. Epidemiology, staging, and management of multiple myeloma. Med. Sci. 9, 3 (2021).

CAS  Google Scholar 

di Martino, E. et al. Incidence trends for twelve cancers in younger adults – a rapid review. Br. J. Cancer 126, 1374–1386 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ludwig, H., Novis Durie, S., Meckl, A., Hinke, A. & Durie, B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist 25, e1406–e1413 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Zhou, L. et al. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer 21, 606 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Huang, J. et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 9, e670–e677 (2022).

Article  CAS  PubMed  Google Scholar 

Ibrahim, A. et al. Management of multiple myeloma in the Middle East: unmet needs, challenges and perspective. Clin. Hematol. Int. 4, 127–132 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Costa, L. J. et al. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 1, 282–287 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Blattner, W. A., Blair, A. & Mason, T. J. Multiple myeloma in the United States, 1950–1975. Cancer 48, 2547–2554 (1981).

Article  CAS  PubMed  Google Scholar 

Mateos, M. V. et al. Global disparities in patients with multiple myeloma: a rapid evidence assessment. Blood Cancer J. 13, 109 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Davey Smith, G., Neaton, J. D., Wentworth, D., Stamler, R. & Stamler, J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 351, 934–939 (1998).

Article  CAS  PubMed  Google Scholar 

Ailawadhi, S. et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood Cancer J. 8, 67 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Bhutani, M., Lonial, S. & Mikhael, J. Disparities in multiple myeloma among African Americans. J. Natl Med. Assoc. 115, S26–S31 (2023).

PubMed  Google Scholar 

Ailawadhi, S. et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 3, 2986–2994 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Ailawadhi, S. et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br. J. Haematol. 158, 91–98 (2012).

Article  PubMed  Google Scholar 

Waxman, A. J. et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 116, 5501–5506 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirtane, K. & Lee, S. J. Racial and ethnic disparities in hematologic malignancies. Blood 130, 1699–1705 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leukemia & Lymphoma Society. Facts 2022-2023. Updated Data on Blood Cancers. Leukemia & Lymphoma Society https://www.lls.org/booklet/facts-updated-data-blood-cancers (2023).

Sant, M. et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 15, 931–942 (2014).

Article  PubMed  Google Scholar 

Chang-Chan, D. Y. et al. Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study. Clin. Transl. Oncol. 23, 1429–1439 (2021).

Article  PubMed  Google Scholar 

Ocias, L. F. et al. Trends in hematological cancer in the elderly in Denmark, 1980-2012. Acta Oncol. 55, 98–107 (2016).

Article  PubMed  Google Scholar 

Canadian Cancer Statistics. A 2022 special report on cancer prevalence. Health Promot. Chronic Dis. Prev. Can. 43, 49 (2023).

Article  Google Scholar 

Sergentanis, T. N. et al. Risk factors for multiple myeloma: a systematic review of meta-analyses. Clin. Lymphoma Myeloma Leuk. 15, 563–577.e3 (2015).

Article  PubMed  Google Scholar 

Lindqvist, E. K. et al. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood 118, 6284–6291 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertelsen, L. D. et al. Geographical and ecological analyses of multiple myeloma in Denmark: identification of potential hotspot areas and impact of urbanisation. Eur. J. Haematol. 110, 289–295 (2023).

Artic